China SXT Pharmaceuticals, Inc. (SXTC): Total Assets
$34.75M
As of 2026-03-31
+5.6%
3-year compound annual growth
+0.1%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $34.75M | +60.4% | 2026-07-01, Balance as of period end |
| 2025-03-31 | $21.66M | -6.3% | 2026-07-01, Balance as of period end |
| 2024-03-31 | $23.13M | -21.7% | 2025-07-31, Balance as of period end |
| 2023-03-31 | $29.55M | -11.9% | 2024-08-13, Balance as of period end |
| 2022-03-31 | $33.55M | -2.9% | 2023-07-31, Balance as of period end |
| 2021-03-31 | $34.55M | +59.2% | 2023-05-19, Balance as of period end |
| 2020-03-31 | $21.70M | +24.2% | 2021-08-13, Balance as of period end |
| 2019-03-31 | $17.47M | +128.1% | 2020-07-31, Balance as of period end |
| 2018-03-31 | $7.66M | n/a | 2019-08-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $34.75M | +60.4% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $359.1K | +1.3% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $28.71M | +0.4% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $32.47M | +46.9% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $48.56M | -42.4% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $8.75M | -11.7% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $91.03M | 0.0% |
Compare SXTC, BSPK, NEUP, LGVN side by side · Screen every company in Pharmaceutical Preparations ↗